Cite
HARVARD Citation
Hedayat, S. et al. (2018). Metastatic colorectal cancer (mCRC) patient derived organoids (PDOs) as a preclinical tool to understand mechanisms of resistance to anti-angiogenic drugs. European journal of surgical oncology. pp. S32-. [Online].